Pregled bibliografske jedinice broj: 274494
Relationship between serum antibody profiles against Helicobacter pylori and gastroduodenal disease outcome
Relationship between serum antibody profiles against Helicobacter pylori and gastroduodenal disease outcome // Gut / Robin C. Watson (ur.).
London : Delhi: British Medical Journals, 2006. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 274494 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Relationship between serum antibody profiles against Helicobacter pylori and gastroduodenal disease outcome
Autori
Filipec-Kanižaj, Tajana ; Katičić, Miroslava ; Presecki, Vladimir ; Prskalo, Marija ; Tićak, Mirjana ; Šabarić, Branka, Naumovski-Mihalic, Slavica ; Čolić-Cvrlje, Vesna ; Škurla, Bruno
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Gut
/ Robin C. Watson - London : Delhi : British Medical Journals, 2006
Skup
14th UEGW
Mjesto i datum
Berlin, Njemačka, 21.10.2006. - 25.10.2006
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Helicobacter pylori; serology; outcome
Sažetak
INTRODUCTION: Infection with Helicobacter pylori is associated with development of a variety of gastroduodenal diseases. Although Helicobacter pylori is common, the development of peptic ulcer disease and gastric carcinoma strikes only a small percentage of carriers.We evaluated the antibodies profiles to Helicobacter pylori virulence proteins to determine a relation between host response and outcome of infection. AIMS & METHODS: The study was conducted on 207 patients undergoing upper endoscopy. The Western blot method was applied to determine the presence of antibodies to p 120 (CagA), p 95 (VacA), p 67 (FSH), p 66 (UreB), p 57 (HSP homolog), p 54 (flagelin), p 33, p 30 (OMP), 29 (UreA), p 26, p19, and p17 proteins of Helicobacter pylori bacteria in the serums of Helicobacter pylori positive patients. The patients were assigned to gropus according to the diagnosis: 46 patients had gastric ulcer, 68 duodenal ulcer, 30 carcinoma, 12 gastric and duodenal ulcer and 51 were diagnosed as non 2 test (STATISTICA ulcer dispepsia. Statistical analysis was performed using for Windows, Release 5.5 H i SPSS for Windows, Release 7.5). RESULTS: P95 (VacA) seropositivity was more freequent in duodenal ulcers and non ulcer dispepsia and less freequent in carcinoma than in all other Helicobacter pylori positive patients (2 14.580, df 4, p <0.006). The p 120 (CagA), p 67 (FSH), p 66 (UreB), p 57 (HSP homolog), p 54 (flagelin), p 33, p 30 (OMP), 29 (UreA), p 26, p19, and p17 response was not seen more frequently in Helicobacter pylori patients with peptic ulcer, carcinoma or non ulcer dyspepsia. CONCLUSION: Host response to p95 (VacA) antigen could indicate patients with higher risk for duodenal ulcer and non ulcer dyspepsia outcome but lower risk for carcinoma outcome.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
0108126
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Mirjana Tićak
(autor)
Marija Prskalo
(autor)
Miroslava Katičić
(autor)
Tajana Filipec Kanižaj
(autor)
Vesna Čolić-Cvrlje
(autor)
Vladimir Presečki
(autor)
Branka Šabarić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE